Skip to main content
. 2020 Mar 24;21(2):275–284. doi: 10.1007/s40257-020-00510-6
Download video file (39.9MB, mp4)

Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: An Open-Label, Phase 4 Study (MP4 40891 MB)